Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
People taking both may find it harder to control cravings or eat less, which could impact their weight loss goals
phase 3 studies are ongoing, and NICE appraisal would be required before NHS availability
Market trends affecting future pricing Several trends are worth watching: New GLP-1 receptor agonists entering the market, including orforglipron , survodutide , and retatrutide , will increase competition and could put downward pressure on tirzepatide pricing across both brand-name and compounded channels
These are real but modest results, especially compared to semaglutide results showing 15-20% body weight reduction
[148] United Kingdom [edit] In the UK, semaglutide is available on NHS prescription for diabetes at nominal or no cost to the individual
US$ 27.85
US$ 28.16
US$ 26.17
US$ 27.36
US$ 26.68
US$ 23.29
